A share price of Bio-Techne Corp [TECH] is currently trading at $54.41, up 3.46%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The TECH shares have gain 2.31% over the last week, with a monthly amount glided 9.08%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bio-Techne Corp [NASDAQ: TECH] stock has seen the most recent analyst activity on July 09, 2025, when TD Cowen initiated its Buy rating and assigned the stock a price target of $65. Previously, Wells Fargo started tracking the stock with Overweight rating on May 30, 2025, and set its price target to $59. On April 09, 2025, downgrade downgraded it’s rating to Sector Weight. Evercore ISI started tracking the stock assigning a Outperform rating and suggested a price target of $75 on March 18, 2025. Robert W. Baird downgraded its rating to a Neutral and reduced its price target to $68 on February 19, 2025. Citigroup downgraded its rating to Neutral for this stock on May 22, 2024, but kept the price target unchanged to $85. In a note dated February 08, 2024, Scotiabank initiated an Sector Outperform rating and provided a target price of $80 on this stock.
Bio-Techne Corp experienced fluctuations in its stock price throughout the past year between $46.01 and $83.62. Currently, Wall Street analysts expect the stock to reach $75 within the next 12 months. Bio-Techne Corp [NASDAQ: TECH] shares were valued at $54.41 at the most recent close of the market. An investor can expect a potential return of 37.84% based on the average TECH price forecast.
Analyzing the TECH fundamentals
Trailing Twelve Months sales for Bio-Techne Corp [NASDAQ:TECH] were 1.21B which represents 4.20% growth. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.06 and Total Capital is 0.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 52.66 points at the first support level, and at 50.91 for the second support level. However, for the 1st resistance point, the stock is sitting at 55.84, and for the 2nd resistance point, it is at 57.28.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Bio-Techne Corp [NASDAQ:TECH] is 3.71. Also, the Quick Ratio is 2.58, while the Cash Ratio stands at 0.83. Considering the valuation of this stock, the price to sales ratio is 7.06, the price to book ratio is 4.23 and price to earnings (TTM) ratio is 66.32.
Transactions by insiders
Recent insider trading involved Herr Amy E., Director, that happened on Jun 09 ’25 when 1280.0 shares were sold. Officer, JOSHUA MOLHO completed a deal on Jun 09 ’25 to buy 1280.0 shares. Meanwhile, Director Herr Amy E. sold 1860.0 shares on Feb 14 ’25.
